Forecast: Domestic Private Health Expenditure in China

Based on the forecasted data, domestic private health expenditure in China is projected to grow consistently from 2024 to 2028. In 2023, this expenditure stood at a certain value, and by 2024 it is expected to increase to $360.12 per capita. Through 2025 to 2028, the expenditure is forecasted to continue rising to $454.18 per capita. The year-on-year variation indicates steady growth, with the increase in expenditure each year being around 6% to 7%. Over the last two years, the annual increase averages around 6.6%, while the Compound Annual Growth Rate (CAGR) over the 5-year period starting in 2024 is approximately 6.0%.

Future trends to watch for include the impact of healthcare reforms, aging population dynamics, and advancements in medical technology which could drive higher private health expenditures. Additionally, economic factors such as inflation rates and income growth will play a significant role in shaping future expenditure trends.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease